What You'll Discover
- How melatonin affects the cardiovascular system
- What studies show about melatonin and heart failure (both sides)
- How melatonin interacts with cardiovascular markers like hsCRP and lipids
- Which markers to test if you have heart health concerns
What Melatonin Does in the Body
Melatonin is a hormone produced by the pineal gland, primarily at night. Its primary role is regulating the sleep-wake cycle. Beyond that, it has documented antioxidant, anti-inflammatory, and immunomodulatory activity.
Research published in PMC describes melatonin as having vasomotor and anti-excitatory cardiovascular effects in addition to its circadian function. Melatonin is also produced in small amounts by heart tissue itself, suggesting a more localized cardiac role than previously understood.
The Cardioprotective Case
Multiple studies found that melatonin reduces oxidative stress and inflammation in cardiac tissue. In animal models of ischemic heart failure, melatonin treatment reversed functional and biochemical abnormalities. The proposed mechanisms include suppressing NF-κB inflammatory pathways, reducing cardiac fibrosis, and protecting mitochondrial function in cardiomyocytes.
A 2025 systematic review and meta-analysis published in Clinical Cardiology analyzed four controlled trials and found that melatonin significantly improved quality of life in heart failure patients (mean difference: -5.95, p = 0.001). Improvements in NYHA functional class and reduced fatigue were also observed.
These findings suggest melatonin may act as a useful adjunct for oxidative and inflammatory processes that drive heart failure progression, though the evidence base remains small.
The Counterpoint: Long-Term Use and Risk
The picture becomes more complicated when you look at real-world supplementation data.
Research presented at the American Heart Association's 2024 Scientific Sessions reviewed five years of health records for more than 130,000 adults with insomnia. Those who used melatonin for at least one year were more likely to be diagnosed with heart failure and require hospitalization compared to those who used other sleep aids.
This was observational, meaning it cannot establish cause and effect. People who take melatonin long-term may have worse underlying sleep and health profiles that independently drive higher cardiovascular risk. But the signal is notable enough to warrant discussion with a clinician if you use melatonin regularly or at higher doses over many months.
It is also worth separating melatonin from the sleep problems it treats. Chronic poor sleep is itself an independent cardiovascular risk factor. Some of the observed association may reflect the health profile of people who need long-term sleep support, not the supplement itself.
What Melatonin Does to Cardiovascular Markers
Research has examined how melatonin supplementation affects measurable biomarkers. A 2025 meta-analysis of 63 randomized controlled trials published in Nutrients found that melatonin significantly reduced serum CRP, TNF-α, and IL-6 levels across diverse clinical populations.
The same research found modest effects on lipid profiles, including reductions in triglycerides and LDL in some populations. Whether short-term marker improvements translate to meaningful long-term cardiovascular risk reduction remains to be established.
ApoB deserves particular attention. Standard LDL measures cholesterol mass, not particle count. ApoB counts every atherogenic particle directly. Research consistently shows ApoB is a stronger predictor of cardiovascular events than LDL, particularly in people with metabolic syndrome or elevated triglycerides, where LDL can significantly underestimate actual particle burden.
hsCRP adds risk information that lipids alone miss. Research published in the Journal of the American College of Cardiology confirms that hsCRP values below 1.0, between 1.0 and 3.0, and above 3.0 mg/L indicate lower, average, and higher relative cardiovascular risk. Understanding how VLDL fits into your overall lipid picture is also useful, particularly if triglycerides are elevated.
FAQ
Does melatonin cause heart failure?
There is no established causal evidence. An observational study found an association between long-term use and heart failure diagnosis, but correlation is not causation. People with worse underlying health may be more likely to use melatonin long-term and to develop heart failure for unrelated reasons.
Can melatonin help people who already have heart failure?
Small clinical trials suggest melatonin may improve quality of life and NYHA functional class in heart failure patients. It is not standard care. Speak with a cardiologist before adding it to any existing cardiac treatment plan.
Is ApoB more useful than LDL for assessing heart risk? Yes, in most cases. ApoB counts atherogenic particles directly, where LDL only measures cholesterol content. The two can diverge significantly in people with high triglycerides or metabolic syndrome. Read the full breakdown in the ApoB ranges and interpretation guide.
Does melatonin affect hsCRP?Research suggests supplementation reduces CRP alongside TNF-α and IL-6. Whether these reductions translate to meaningful long-term cardiovascular benefit is not yet established from long-duration trials.
Should I stop taking melatonin if I have heart concerns?
Do not start or stop any supplement without speaking to a clinician. If you have existing cardiovascular disease or multiple risk factors, reviewing your supplement list with your doctor is reasonable. You may also want to review how heart and liver health connect when assessing cardiovascular risk more broadly.
Summary
The relationship between melatonin and heart failure is genuinely complex. Short-term trials support cardioprotective effects through anti-inflammatory and antioxidant mechanisms. Long-term observational data raises questions that remain unresolved. More prospective research is needed.
What is clear: cardiovascular risk is measurable. Markers like ApoB, Lp(a), hsCRP, and a full lipid panel give you a precise picture of what is happening in your arteries and bloodstream, independent of any one supplement. Tracking these numbers over time is what separates guesswork from informed decisions.
If you want to understand where you actually stand, start with your numbers.
This article is for educational purposes only and does not constitute medical advice. Always speak with a qualified clinician before starting or stopping any supplement, particularly if you have existing cardiovascular disease or risk factors.
